3 Firms Draw Up Pfizer's $6.7B Arena Pharmaceuticals Buy
Pfizer, led by Ropes & Gray and Arnold & Porter, will pay roughly $6.7 billion to buy Cooley-counseled Arena Pharmaceuticals, which develops treatments for immuno-inflammatory diseases, the companies said Monday....To view the full article, register now.
Already a subscriber? Click here to view full article